MiraLAX (Polyethylene Glycol 3350) for Fecal Impaction
MiraLAX at the standard FDA-approved dose of 17 g daily is NOT appropriate for treating fecal impaction—you need significantly higher doses (1-1.5 g/kg/day) for disimpaction, which is an off-label use. The FDA has only approved the 17 g daily dose for occasional constipation, not for fecal impaction 1.
Dosing for Fecal Impaction (Off-Label)
Pediatric Dosing
For children with fecal impaction, use 1-1.5 g/kg/day of PEG 3350 for 3 days 2. This dose-response study demonstrated:
- 95% disimpaction success at the higher doses (1 and 1.5 g/kg/day)
- Only 55% success at lower doses (0.25-0.5 g/kg/day)
- Significant increase in bowel movements across all groups
- Safe electrolyte profile with no clinically significant changes
Alternative aggressive regimen: 3-4.1 g/kg/day orally combined with enema therapy (0.975-1.625 g/kg/day) has shown superior efficacy in hospitalized children with severe impaction 3. This combined approach achieved disimpaction in all patients without electrolyte abnormalities.
Adult Dosing (Extrapolated)
While the guidelines focus on chronic constipation rather than acute impaction, the evidence suggests:
- Standard maintenance dose: 17 g daily mixed in 8 ounces of liquid 4
- For impaction: Higher doses are needed, though specific adult impaction protocols are not well-established in the provided evidence
- The pediatric data suggests doses of 1-1.5 g/kg/day would translate to approximately 70-105 g daily for a 70 kg adult for 3 days
Administration Details
Mix the powder in 8 ounces (240 mL) of any beverage 1. The powder is unflavored and grit-free, dissolving completely in liquids.
Duration:
- For disimpaction: 3 days at high dose 2
- Median time to disimpaction in pediatric studies: 6 days (range 3-7 days) 5
Important Clinical Considerations
Expected Adverse Effects
Common side effects increase with higher doses 2:
- Bloating (18%)
- Diarrhea (13%)—more prevalent at higher doses
- Nausea (5%)
- Vomiting (5%)
- Cramping (5%)
These effects are dose-dependent and more common with the high doses needed for disimpaction 2.
Monitoring
- No routine electrolyte monitoring needed for short-term use (3 days)
- Multiple studies showed no clinically significant electrolyte changes even at high doses 2, 3
When PEG Alone May Not Be Sufficient
Consider adding a stimulant laxative (sodium picosulphate) if:
- Initial PEG monotherapy fails after 2-3 days
- Severe, long-standing impaction (>2 years duration)
- Palpable fecaloma present
The combination of PEG + stimulant laxative showed superior disimpaction rates compared to PEG alone in pediatric studies 6, 7.
Comparison with Other Approaches
PEG is superior to enemas for patient comfort but may be slower:
- Enemas provide faster symptom relief (day 1) but upset 54% of children
- PEG causes no distress but takes longer for initial improvement 8
- By day 5, outcomes are equivalent
PEG is significantly more effective than lactulose:
- 0% reimpaction rate with PEG vs 23% with lactulose during maintenance 5
- Better long-term constipation control
Critical Pitfall to Avoid
Do not use the standard 17 g daily dose for fecal impaction—this is only for occasional constipation maintenance. You will under-treat the patient and fail to achieve disimpaction. The evidence clearly shows a dose-response relationship, with higher doses (1-1.5 g/kg/day) required for effective disimpaction 2.
Transition to Maintenance
After successful disimpaction (typically 3-7 days), transition to: